Boston Scientific Corporation (LON:0HOY)
| Market Cap | 82.03B -32.9% |
| Revenue (ttm) | 14.91B +19.9% |
| Net Income | 2.15B +56.4% |
| EPS | 1.44 +55.2% |
| Shares Out | n/a |
| PE Ratio | 38.09 |
| Forward PE | 21.38 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,656 |
| Average Volume | 14,605 |
| Open | 76.09 |
| Previous Close | 76.11 |
| Day's Range | 74.61 - 76.72 |
| 52-Week Range | 72.84 - 109.51 |
| Beta | 0.66 |
| RSI | 30.61 |
| Earnings Date | Feb 4, 2026 |
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra... [Read more]
Financial Performance
In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.
Financial numbers in USD Financial StatementsNews
Back on the Radar: Prior Picks Offer Fresh Opportunity
Sometimes the best new ideas are simply old winners ready for another run.
Vanguard Russell 1000 Value Index Fund Buys 4,738 Shares of Boston Scientific Corp (BSX)
Vanguard Russell 1000 Value Index Fund Buys 4,738 Shares of Boston Scientific Corp (BSX)
Vanguard U.S. Momentum Factor ETF Sells 51,663 Shares of Boston Scientific Corp (BSX)
Vanguard U.S. Momentum Factor ETF Sells 51,663 Shares of Boston Scientific Corp (BSX)
Vanguard U.S. Growth Fund Sells 1,821,665 Shares of Boston Scientific Corp (BSX)
Vanguard U.S. Growth Fund Sells 1,821,665 Shares of Boston Scientific Corp (BSX)
PGIM Quant Solutions Large-Cap Value Fund Buys 2,300 Shares of Boston Scientific Corp (BSX)
PGIM Quant Solutions Large-Cap Value Fund Buys 2,300 Shares of Boston Scientific Corp (BSX)
Goldman Sachs Large Cap Value Fund Sells 1,806 Shares of Boston Scientific Corp (BSX)
Goldman Sachs Large Cap Value Fund Sells 1,806 Shares of Boston Scientific Corp (BSX)
Peering Into Boston Scientific Corp's Recent Short Interest
Boston Scientific Corp's (NYSE: BSX) short interest as a percent of float has risen 20.89% since its last report. According to exchange reported data, there are now 28.28 million shares sold short , ...
Symmetry Panoramic Global Equity Fund Buys 603 Shares of Boston Scientific Corp (BSX)
Symmetry Panoramic Global Equity Fund Buys 603 Shares of Boston Scientific Corp (BSX)
FOCUSED GLOBAL GROWTH FUND Sells 5,480 Shares of Boston Scientific Corp (BSX)
FOCUSED GLOBAL GROWTH FUND Sells 5,480 Shares of Boston Scientific Corp (BSX)
Avantis U.S. Equity ETF Buys 3,077 Shares of Boston Scientific Corp (BSX)
Avantis U.S. Equity ETF Buys 3,077 Shares of Boston Scientific Corp (BSX)
Avantis U.S. Large Cap Equity ETF Buys 1,131 Shares of Boston Scientific Corp (BSX)
Avantis U.S. Large Cap Equity ETF Buys 1,131 Shares of Boston Scientific Corp (BSX)
EVERGREEN CAPITAL MANAGEMENT LLC Buys 6,736 Shares of Boston Scientific Corp (BSX)
EVERGREEN CAPITAL MANAGEMENT LLC Buys 6,736 Shares of Boston Scientific Corp (BSX)
American Century U.S. Quality Growth ETF Sells 70,912 Shares of Boston Scientific Corp (BSX)
American Century U.S. Quality Growth ETF Sells 70,912 Shares of Boston Scientific Corp (BSX)
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference
MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026.
See Which Of The Latest 13F Filers Holds BSX
At Holdings Channel, we have reviewed the latest batch of the 25 most recent 13F filings for the 12/31/2025 reporting period, and noticed that Boston Scientific Corp. (Symbol: BSX) was held by 10 of t...
Xtrackers MSCI USA Climate Action Equity ETF Buys 1,568 Shares of Boston Scientific Corp (BSX)
Xtrackers MSCI USA Climate Action Equity ETF Buys 1,568 Shares of Boston Scientific Corp (BSX)
Xtrackers S&P 500 Growth Scored & Screened ETF Sells 513 Shares of Boston Scientific ...
Xtrackers S&P 500 Growth Scored & Screened ETF Sells 513 Shares of Boston Scientific Corp (BSX)
Trade Tracker: Monolithic Power, Astera Labs, Genpact, Pinnacle Financial, First Citizens Bank, HealthEquity, Boston Scientific and the XBI
The Investment Committee detail their latest portfolio moves.
Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Buys 256 Shares of Boston Scientific ...
Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Buys 256 Shares of Boston Scientific Corp (BSX)
Goldman Sachs MarketBeta U.S. Equity ETF Buys 2,783 Shares of Boston Scientific Corp (BSX)
Goldman Sachs MarketBeta U.S. Equity ETF Buys 2,783 Shares of Boston Scientific Corp (BSX)
Goldman Sachs Large Cap Equity Fund Sells 65,897 Shares of Boston Scientific Corp (BSX)
Goldman Sachs Large Cap Equity Fund Sells 65,897 Shares of Boston Scientific Corp (BSX)
Systematic Core Fund Buys 1,544 Shares of Boston Scientific Corp (BSX)
Systematic Core Fund Buys 1,544 Shares of Boston Scientific Corp (BSX)
U.S. Socially Responsible Fund Buys 654 Shares of Boston Scientific Corp (BSX)
U.S. Socially Responsible Fund Buys 654 Shares of Boston Scientific Corp (BSX)
Growth Fund Sells 17,986 Shares of Boston Scientific Corp (BSX)
Growth Fund Sells 17,986 Shares of Boston Scientific Corp (BSX)
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific...